RenovoRx, Inc. (RNXT)
0.98
+0.01
(+1.03%)
USD |
NASDAQ |
Apr 02, 16:00
0.9808
0.00 (0.00%)
After-Hours: 20:00
RenovoRx EPS Diluted (Quarterly) : -0.0803 for Dec. 31, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| SELLAS Life Sciences Group, Inc. | -0.05 |
| BioRestorative Therapies, Inc. | -0.3614 |
| CytomX Therapeutics, Inc. | -0.1734 |
| Celcuity, Inc. | -0.9702 |
| TELA Bio, Inc. | -0.1749 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -2.941M |
| Revenue (Quarterly) | 0.238M |
| Total Expenses (Quarterly) | 3.179M |
| Enterprise Value | 37.34M |
| Gross Profit Margin (Quarterly) | 88.24% |
| Profit Margin (Quarterly) | -1.24K% |
| Earnings Yield | -32.26% |
| Normalized Earnings Yield | -34.21 |